ABILIFY tv commercials
TV spots
TV commercials ABILIFY
ABILIFY is a medication used to treat depression and other mental health conditions. The TV commercial for ABILIFY uses an umbrella symbol as a metaphor for the medication's ability to provide coverage and support to those struggling with depression.In the commercial, we see a person walking with an...
ABILIFY TV Spot, 'Add Abilify' is a commercial that promotes the usage of Abilify – a medication used to treat mental illnesses. The ad showcases the struggles and emotional turmoil that people with depression, bipolar disorder, and schizophrenia go through in their daily lives. The visuals portray...
Title: ABILIFY TV Spot: Terri and Team: "Introducing ABILIFY, the prescription medication that's here to empower individuals battling mental health challenges. In this engaging TV spot, we meet Terri and her Team, who have discovered the strength within themselves with the help of ABILIFY.": "Meet T...
Agenices
Agencies worked with ABILIFY
Wavemaker
Wavemaker is a global advertising company that specializes in helping businesses connect with their target audiences through innovative marketing strategies. The company was formed as a merger between two media giants, Maxus and MEC, and officially launched in 2018.Headquartered in London, United Kingdom, Wavemaker operates in over 90 countries worldwide, with over 8,500 employees working in more than 100 offices. The company's mission is to prov...
Actors
Actors who starred in ABILIFY commercials
What kind of company is ABILIFY?
ABILIFY
ABILIFY is a brand name for the drug aripiprazole, which is used to treat schizophrenia, bipolar disorder, and depression. It is manufactured by Bristol-Myers Squibb in partnership with Otsuka Pharmaceutical Company. The medication was first approved by the US FDA in 2002, and has been used to treat various mental illnesses since then.
ABILIFY MyCite
In 2017, ABILIFY became the first drug in the US to be approved by the FDA with a digital ingestion tracking system. ABILIFY MyCite is a type of the drug with a built-in sensor that communicates with a patch worn on the skin. The patch records the time of ingestion and transmits the information to a smartphone app that patients can download. The app can also share the information with healthcare providers and family members with the patient's consent.
Lawsuits and Controversies
ABILIFY has faced several lawsuits in the US, Canada, and other countries from patients who claimed the medication caused them to develop compulsive behaviors, including gambling, binge eating, and hypersexuality. In 2019, Bristol-Myers Squibb and Otsuka America Pharmaceutical settled with thousands of people who sued the companies over compulsive behavior they blamed on ABILIFY. The terms of the settlement were confidential.
Additionally, the US Department of Justice accused Bristol-Myers Squibb of promoting ABILIFY off-label for use in children and for treating various conditions for which it had not been approved. Bristol-Myers Squibb paid a $515 million settlement in 2007 to resolve these allegations.
